{
    "Title": "“Cheaper and better”: Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia",
    "URL": "https://doi.org/10.1371/journal.pntd.0007788",
    "Published": "November 6, 2019",
    "Subject_Areas": [
        "Health economics",
        "Leishmaniasis",
        "Budgets",
        "Drug administration",
        "Drug therapy",
        "Ulcers",
        "Adverse reactions",
        "Health care facilities"
    ],
    "Authors": {
        "Daniel Eid Rodríguez": [
            "Department of Biomedical Sciences Research, Faculty of Medicine, San Simon University, Cochabamba, Bolivia",
            "Department of Epidemiology and Global Health, Faculty of Medicine, Umeå University, Umeå, Sweden"
        ],
        "Miguel San Sebastian": [
            "Department of Epidemiology and Global Health, Faculty of Medicine, Umeå University, Umeå, Sweden"
        ],
        "Anni-Maria Pulkki-Brännström": [
            "Department of Epidemiology and Global Health, Faculty of Medicine, Umeå University, Umeå, Sweden"
        ]
    }
}